Cynosure Group LLC Makes New $328,000 Investment in The Procter & Gamble Company (NYSE:PG)

Cynosure Group LLC bought a new stake in shares of The Procter & Gamble Company (NYSE:PG) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,896 shares of the company’s stock, valued at approximately $328,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in PG. Itau Unibanco Holding S.A. purchased a new stake in Procter & Gamble in the second quarter worth $28,000. Fairway Wealth LLC bought a new position in Procter & Gamble during the second quarter worth about $29,000. POM Investment Strategies LLC bought a new stake in shares of Procter & Gamble in the second quarter valued at approximately $34,000. Quest Partners LLC purchased a new stake in shares of Procter & Gamble during the 2nd quarter valued at approximately $36,000. Finally, Fairfield Financial Advisors LTD bought a new position in Procter & Gamble in the 2nd quarter worth approximately $44,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Procter & Gamble

In other news, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the transaction, the insider now directly owns 11,595 shares of the company’s stock, valued at approximately $2,002,804.35. The trade was a 52.47 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares of the company’s stock, valued at $3,319,882.65. The trade was a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 35,233 shares of company stock worth $6,024,234 in the last three months. 0.18% of the stock is owned by insiders.

Procter & Gamble Price Performance

Shares of Procter & Gamble stock opened at $179.37 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $180.43. The company has a fifty day moving average of $170.48 and a 200-day moving average of $169.07. The stock has a market capitalization of $422.42 billion, a price-to-earnings ratio of 30.93, a price-to-earnings-growth ratio of 3.86 and a beta of 0.42.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same period in the prior year, the business posted $1.83 earnings per share. The company’s revenue was down .6% on a year-over-year basis. Equities research analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.24%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s payout ratio is 69.31%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on PG. Morgan Stanley boosted their price objective on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Royal Bank of Canada reissued a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective for the company in a research note on Thursday, August 29th. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a report on Monday, September 30th. Finally, Piper Sandler initiated coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective on the stock. Eight investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $180.45.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.